Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Nuwellis (GB:0HQX)
LSE:0HQX
Nuwellis (0HQX) Share Price & Analysis
0 Followers
0HQX Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
Nuwellis News
PremiumPress Releases
Nuwellis Announces Plan for CFO Transition
0HQX FAQ
What was Nuwellis’s price range in the past 12 months?
Currently, no data Available
What is Nuwellis’s market cap?
Currently, no data Available
When is Nuwellis’s upcoming earnings report date?
Nuwellis’s upcoming earnings report date is Nov 07, 2023 which is 171 days ago.
How were Nuwellis’s earnings last quarter?
Nuwellis released its earnings results on Aug 08, 2023. The company reported -$3.65 earnings per share for the quarter, beating the consensus estimate of -$4.023 by $0.373.
Is Nuwellis overvalued?
According to Wall Street analysts Nuwellis’s price is currently Undervalued.
Does Nuwellis pay dividends?
Nuwellis does not currently pay dividends.
What is Nuwellis’s EPS estimate?
Nuwellis’s EPS estimate is -$3.29.
How many shares outstanding does Nuwellis have?
Currently, no data Available
What happened to Nuwellis’s price movement after its last earnings report?
Nuwellis reported an EPS of -$3.65 in its last earnings report, beating expectations of -$4.023. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Nuwellis?
Currently, no hedge funds are holding shares in GB:0HQX
---
Nuwellis Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$10.00 (― Upside)
$10.00 (― Upside)
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
241.53%
12-Months-Change
Fundamentals
Return on Equity
-118.98%
Trailing 12-Months
Asset Growth
-29.30%
Trailing 12-Months
Company Description
Nuwellis
CHF Solutions, Inc. is a medical device company, which engages in the provision of products for the treatment of fluid overload. Its product include Aquadex FlexFlow System, which provides an ultrafiltration for the removal of salt and water in patients with hypervolemia, or fluid overload. It operates through Cardiac and Coronary Disease Products segment. The company was founded by Crispin Marsh and William S. Peters in November 1999 and is headquartered in Eden Prairie, MN.
---
0HQX Stock 12 Months Forecast
Average Price Target
―Best Analysts Covering 0HQX
1 Year
1 Year Success Rate
4/16 ratings generated profit
1 Year Average Return
+84.69%
reiterated a buy rating 9 months ago
Copying Anthony Vendetti's trades and holding each position for 1 Year would result in 25.00% of your transactions generating a profit, with an average return of +84.69% per trade.
---